The Miami Entrepreneur

Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years

Read Time:5 Second

The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post The 2024 box office is a franchise frenzy — at a time when audiences are feeling IP fatigue
Next post Cruise stocks pull back after record 2023 gains, led by Norwegian, Royal Caribbean share selloffs